Grant Text and Funding Citation Resources
Writing a grant? Need text for a resources section? Need a letter of support for a grant application? Find resources that can help with the grant application and funding process from start to finish below.
CTSI Facilities and Resources
Writing a grant? Need text for a resources section? You may copy and paste the text, and the text-only version may be easier to use. If you notice any text that needs to be updated or have any other questions, please contact CTSI Communications.
- View the comprehensive Facilities and Other Resources Word document (this version includes photos, figures, tables and graphics) – living document
- Download the same Facilities and Other Resources (no graphics) Word document, without graphics- last updated 2023.
Letters of Support
Need a letter of support for a grant application? Fielding an inquiry from a researcher who needs a letter?
Please provide the following:
- Project Title
- Specific Aims Page
- Date Letter of Support Needed
Note: Each request is reviewed for alignment with NIH priorities.
Please route requests to UF CTSI director of operations, Mendy Dunn, and research administration manager, April Braxton.
CTSA Funding Citations
The University of Florida Clinical and Translational Science Institute and its CTSA hub partner, Florida State University, are supported in part by three Clinical and Translational Science Award (CTSA) Program grants awarded on July 1, 2025, and renewed for seven years, by the National Center for Advancing Translational Sciences of the National Institutes of Health.
The UF-FSU CTSA grant numbers are UM1TR005128, K12TR005129, T32TR005120. For the 2025-2032 project period, each grant year begins July 1 and ends June 30. The UM1 award covers operations of the CTSA hub outside of its K12 junior faculty and T23 predoctoral trainee programs.
In accordance with NIH requirements, all publications, news releases or other documents about research supported in whole or in part by the UF-FSU CTSA hub or its services must cite the appropriate NIH grant number(s) and ensure compliance with the NIH Public Access Policy (see resources below). Each publication, press release, or other document about research supported by an NIH award must include an acknowledgment of NIH award support and a disclaimer.
Below is recommended language for UF investigators based on the type of support received. Thanks for remembering to cite the CTSA and submit your publications to PubMed Central!
- K12 Scholars:
Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number K12TR005129. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH. - T32 Trainees:
Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number T32TR005120. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH. - All other support (including TRACTS, Pilot Awards and use of the UF Clinical Research Center, REDCap and any other CTSI-supported service or facility):
Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UM1TR005128. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH.
For more detailed information on NIH compliance visit Smather’s Library Libguide
Previous UF CTSA Grant Numbers
- 2009 – 2011: UL1RR029890, KL2RR029888, TL1RR029889
- 2012 – Sep. 30, 2015: UL1 TR000064, KL2 TR000065, TL1 TR000066
- 2015 – Aug. 31, 2025: TL1TR001428
- 2015 – Jun. 30, 2025: UL1TR001427, KL2TR001429
NIH Public Access Policy
Federal law requires all published peer-reviewed manuscripts funded at least in part by the NIH to be submitted in full-text to PubMed Central. Please coordinate with your accepting journal to ensure timely processing of the manuscript by the NIH Manuscript Submission System (NIHMS). See instructions in this PDF document: Open Access Compliance Instructions. Assistance is provided by the CTSI and the Health Science Center Libraries’ liaison librarians.
Designating Indirect Cost Distributions
How the CTSI Uses IDC Distributions
The CTSI uses IDC distributions to sustain subsidized access to its many services and resources for translational researchers — resources such as the Clinical Research Center, Clinical Research Vehicle, REDCap, UF Health Integrated Data Repository, pilot grants, training programs, core laboratory facilities and services, regulatory and biostatistics support, and more.
How to Select the CTSI for IDC Distributions
If you accrued indirect costs in the past fiscal year, you should have received an email from the Office of Research directing you to indicate IDC distributions. Annually, the deadline to indicate these IDCs is June 30 via the myUFL Enterprise Analytics system. Here’s how to designate:
- Updates to center return distributions can be completed via a UFIRST Activity. For details regarding your current sponsored project distributions, please login using your Gatorlink at https://reporting.it.ufl.edu/. Navigate to Team Content > Sponsored Program Information > Awards > Center Return.
- To allocate a portion of your IDCs to the CTSI, select the following overhead account information:
- DEPTID:29680000
- Department: MD-CTSI
- Overhead: 00082127
- PS Project Title: CTR-OH
Review instructions from the UF Office of Research.
additional support
Contribute to the advancement of clinical research
Generous additional support for the UF CTSI comes from the UF Office of Research and UF Health. Additional support comes from in-kind contributions from various units. Private support is welcomed.